New articles
24.07.2021
Resistance to drug treatment of acromegaly and ways to overcome it
Golounina O. O., Dzeranova L. K., Pigarova E. A., Belaya Zh. E. 
10.14341/omet12710
Acromegaly is a severe disabling neuroendocrine disease caused by hypersecretion of growth hormone (GH) and insulin-like growth factor 1 (IGF-1). The ...
24.07.2021
The frequency of metabolic syndrome and its individual components in women aged 25–45 years, depending on the level of prolactin
Rymar O. D., Voevoda S. M., Shakhtshneider E. V., Stakhneva E. M., Mustafina S. V., Shcherbakova L. V.
10.14341/omet12475
Background: Hyperprolactinemia is one of the most common hypothalamic-pituitary-endocrine disorders in women of reproductive age, with the highest fre...
24.07.2021
Polymorphic variants of ACE, AGT, AGTR1, MTHFR and NOS3 candidate genes connected with arterial hypertension as part of the metabolic syndrome among the shor people
Mulerova T. A., Tsygankova D. P., Ogarkov M. Yu.
10.14341/omet12295
Background: The problem of high blood pressure in the framework of metabolic syndrome (MS) is one of the most important for modern medicine in connect...
24.07.2021
Efficacy of metformin for treatment and prevention of antipsychotic-induced overweight and obesity in women: an open-label, randomized, prospective placebo-controlled study
Yunilaynen O. A., Oleichik I. V., Sizov S. V., Baranov P. A., Starostina E. G.
10.14341/omet12684
Background: The prevalence of obesity and metabolic abnormalities is increased patients with mental disorders receiving psychopharmacotherapy, which s...
24.07.2021
Association of the rs2167270 polymorphism of the leptin gene (LEP) with the intensity of pain in patients with osteoarthritis of the knee
Krylov M. Yu., Alekseeva L. I., Scharapova E. P.
10.14341/omet10189
Background: Osteoarthritis (OA) is a significant social problem as it is the most common disease of the joints. OA is a multifactorial disease in whic...
24.07.2021
Risk Factors for Obesity Development in Different Periods of Childhood
Chubarov T. V., Bessonova A. V., Zhdanova O. A., Artyushchenko A. A., Sharshova O. G.
10.14341/omet12756
Obesity is an important health problem in many countries. Obesity among the child population is growing steadily, including the Russian Federation. De...
24.07.2021
The importance of melatonin in the regulation of metabolism, eating behavior, sleep, and the prospects for the use of melatonin drugs for obesity treatment
Tsvetkova E. S., Romantsova T. I., Poluektov M. G., Runova G. E., Glinkina I. V., Fadeev V. V.
10.14341/omet12279
Melatonin is a special hormone that act as an internal synchronizer of circadian rhythms, the organism physiology and behavior to the environmental da...
24.07.2021
Daily calcium profile in diagnosis of hypo- and hypercalcemia in patients with chronic hypoparathyroidism. clinical case series
Kovaleva E. V., Eremkina A. K., Mokrysheva N. G.
10.14341/omet12729
Hypoparathyroidism is a rare endocrine disorder characterized by hypocalcemia and hyperphosphatemia, due to absent or inappropriately low serum parath...
24.07.2021
Comparison of the effects of liraglutide and sibutramine in obese patients
Matveev G. A., Golikova T. I., Vasileva A. A., Vasilieva E. V., Babenko A. Y., Shlyakhto E. V.
10.14341/omet12498
Background: Obesity is a global noncommunicable pandemic. The low effectiveness of treating obesity is associated with the difficulty of maintaining w...
24.07.2021
To the question of the pathogenetic mechanisms of the influence of obesity on the level of vitamin D
Suplotova L. A., Avdeeva V. A., Rozhinskaya L. Y.
10.14341/omet12578
The influence of obesity on human health, as a multifactorial and multigenic disorder, is a rather complex, interdisciplinary and at the same time ext...